As Abbvie (ABBV) Market Value Rose, Shareholder Supplemental Annuity Collective Trust Of Nj Has Lowered Its Holding; Pekin Singer Strauss Asset Management Has Upped Its Sk Telecom LTD (SKM) Position by $473,976

February 23, 2018 - By Henry Gaston

Pekin Singer Strauss Asset Management increased its stake in Sk Telecom Ltd (SKM) by 2.79% based on its latest 2017Q3 regulatory filing with the SEC. Pekin Singer Strauss Asset Management bought 19,749 shares as the company’s stock rose 11.01% with the market. The institutional investor held 726,889 shares of the public utilities company at the end of 2017Q3, valued at $17.87 million, up from 707,140 at the end of the previous reported quarter. Pekin Singer Strauss Asset Management who had been investing in Sk Telecom Ltd for a number of months, seems to be bullish on the $15.26 billion market cap company. The stock increased 0.25% or $0.06 during the last trading session, reaching $24.5. About 716,628 shares traded or 47.63% up from the average. SK Telecom Co., Ltd. (NYSE:SKM) has risen 24.69% since February 23, 2017 and is uptrending. It has outperformed by 7.99% the S&P500.

Supplemental Annuity Collective Trust Of Nj decreased its stake in Abbvie Inc (ABBV) by 24.43% based on its latest 2017Q3 regulatory filing with the SEC. Supplemental Annuity Collective Trust Of Nj sold 4,849 shares as the company’s stock rose 6.17% with the market. The institutional investor held 15,000 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.33 million, down from 19,849 at the end of the previous reported quarter. Supplemental Annuity Collective Trust Of Nj who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $188.57B market cap company. The stock increased 1.01% or $1.19 during the last trading session, reaching $118.75. About 4.47 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since February 23, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Among 5 analysts covering SK Telecom (NYSE:SKM), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. SK Telecom had 5 analyst reports since November 2, 2015 according to SRatingsIntel. Citigroup upgraded the shares of SKM in report on Friday, December 1 to “Buy” rating. As per Monday, October 24, the company rating was upgraded by CLSA. The stock of SK Telecom Co., Ltd. (NYSE:SKM) earned “Neutral” rating by JP Morgan on Monday, November 2. The stock has “Neutral” rating by Macquarie Research on Tuesday, October 25. The rating was downgraded by HSBC to “Hold” on Wednesday, April 27.

Pekin Singer Strauss Asset Management, which manages about $1.07B and $533.43 million US Long portfolio, decreased its stake in Jones Lang Lasalle Inc (NYSE:JLL) by 6,870 shares to 122,893 shares, valued at $15.18 million in 2017Q3, according to the filing. It also reduced its holding in Air Lease Corp (NYSE:AL) by 29,115 shares in the quarter, leaving it with 250,827 shares, and cut its stake in Sprott Physical Gold Trust (PHYS).

Supplemental Annuity Collective Trust Of Nj, which manages about $227.65M US Long portfolio, upped its stake in Boeing Co (NYSE:BA) by 2,000 shares to 6,000 shares, valued at $1.53M in 2017Q3, according to the filing. It also increased its holding in Harley Davidson Inc (NYSE:HOG) by 8,000 shares in the quarter, for a total of 20,000 shares, and has risen its stake in Finisar Corp (NASDAQ:FNSR).

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 48% are positive. Abbvie Inc had 78 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of AbbVie Inc. (NYSE:ABBV) has “Market Perform” rating given on Monday, June 6 by Cowen & Co. Jefferies maintained the shares of ABBV in report on Tuesday, January 16 with “Buy” rating. Jefferies maintained it with “Buy” rating and $120.0 target in Thursday, January 4 report. BMO Capital Markets downgraded the stock to “Underperform” rating in Tuesday, January 30 report. BMO Capital Markets downgraded the stock to “Market Perform” rating in Friday, June 10 report. The company was downgraded on Wednesday, June 8 by Morgan Stanley. The rating was upgraded by Leerink Swann on Monday, October 2 to “Outperform”. Citigroup upgraded AbbVie Inc. (NYSE:ABBV) on Tuesday, February 23 to “Buy” rating. Jefferies maintained AbbVie Inc. (NYSE:ABBV) on Friday, August 18 with “Buy” rating. The firm has “Buy” rating by Argus Research given on Friday, February 2.

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. It dropped, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. Brown Advisory accumulated 819,779 shares. 29,347 are held by Coe Mngmt Lc. Missouri-based Acropolis Inv Mgmt Limited Com has invested 0.02% in AbbVie Inc. (NYSE:ABBV). Moreover, First Trust Advsr Ltd Partnership has 0.3% invested in AbbVie Inc. (NYSE:ABBV) for 1.30M shares. Lee Danner Bass Incorporated holds 13,662 shares. Cwm Ltd Liability Company reported 0.29% stake. Tirschwell & Loewy Inc has 1.73% invested in AbbVie Inc. (NYSE:ABBV). Jpmorgan Chase And Company holds 3.47M shares or 0.07% of its portfolio. Farmers Tru reported 37,732 shares. Cibc Bancorp Usa owns 39,978 shares. 224,812 were reported by Fincl Engines Advsrs Ltd Liability. Aperio Gp Ltd Liability owns 865,283 shares. Fisher Asset Mgmt Llc reported 683,274 shares. 4,907 were reported by Personal Cap Advsrs. Eastern Financial Bank invested in 62,978 shares.

Since September 11, 2017, it had 0 insider purchases, and 6 selling transactions for $25.71 million activity. 8,300 shares were sold by SALEKI-GERHARDT AZITA, worth $705,655 on Monday, September 11. Schumacher Laura J also sold $14.07M worth of AbbVie Inc. (NYSE:ABBV) shares. Another trade for 87,040 shares valued at $8.57 million was made by RICHMOND TIMOTHY J. on Monday, December 18. Gosebruch Henry O sold 18,300 shares worth $1.66M.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on April, 26. They expect $1.78 EPS, up 39.06% or $0.50 from last year’s $1.28 per share. ABBV’s profit will be $2.83 billion for 16.68 P/E if the $1.78 EPS becomes a reality. After $1.48 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 20.27% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: